EE57 Healthcare Costs Avoided in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura with Caplacizumab in Colombia
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.362
https://www.valueinhealthjournal.com/article/S1098-3015(23)00462-X/fulltext
Title :
EE57 Healthcare Costs Avoided in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura with Caplacizumab in Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00462-X&doi=10.1016/j.jval.2023.03.362
First page :
Section Title :
Open access? :
No
Section Order :
11742